Literature DB >> 6987045

Psychosocial concomitants to rehabilitation in chronic obstructive pulmonary disease. Part 2. Psychosocial treatment.

D L Dudley, E M Glaser, B N Jorgenson, D L Logan.   

Abstract

Entities:  

Mesh:

Year:  1980        PMID: 6987045     DOI: 10.1378/chest.77.4.544

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

1.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

Review 2.  Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review.

Authors:  L van Ede; C J Yzermans; H J Brouwer
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

3.  Randomised controlled trial of the effectiveness of a respiratory health worker in reducing impairment, disability, and handicap due to chronic airflow limitation.

Authors:  P Littlejohns; C M Baveystock; H Parnell; P W Jones
Journal:  Thorax       Date:  1991-08       Impact factor: 9.139

4.  The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorder.

Authors:  E Sherwood Brown; Michelle Murray; Thomas J Carmody; Beth D Kennard; Carroll W Hughes; David A Khan; A John Rush
Journal:  Ann Allergy Asthma Immunol       Date:  2008-05       Impact factor: 6.347

Review 5.  Strategies to improve anxiety and depression in patients with COPD: a mental health perspective.

Authors:  Athanasios Tselebis; Argyro Pachi; Ioannis Ilias; Epaminondas Kosmas; Dionisios Bratis; Georgios Moussas; Nikolaos Tzanakis
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-09       Impact factor: 2.570

6.  Relaxation Techniques for People with Chronic Obstructive Pulmonary Disease: A Systematic Review and a Meta-Analysis.

Authors:  Eleonora Volpato; Paolo Banfi; Sheena Michelle Rogers; Francesco Pagnini
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-03       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.